Traditionally, vaccines protect against one particular pathogen, but in this study, Stanford Medicine researchers created a vaccine that successfully offered immunity from respiratory viruses, ...

A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...

Reversing its initial decision, the FDA has agreed to review Moderna’s messenger RNA-based influenza vaccine for approval, the company announced Wednesday. The reversal about weeks after the FDA sent ...

FDA reverses course, will review Moderna’s new mRNA flu vaccine.

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and ...

Politico has reported that the White House isn’t happy with the FDA’s recent actions surrounding vaccines, fueling public scrutiny of internal decision-making at the regulator. | Politico has reported ...

The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.

Raw oysters harvested from British Columbia, Canada, in the past 2 months may be contaminated with norovirus, the FDA warned. HHS Secretary Robert F. Kennedy Jr. and musician Kid Rock appeared ...

The FDA’s drug review process can often be "unpredictable," and review teams typically “differ greatly” in what they ask of drug sponsors, Sen. Bill Cassidy said.

The Food and Drug Administration agreed Wednesday to review Moderna’s application to make a new seasonal flu shot available, after initially refusing to do so. The back-and-forth reveals increased ...

More parents are skipping childhood vaccines after the COVID-19 pandemic as vaccines become a flashpoint in American politics and culture. The post How the search for vaccine safety led parents away ...

Turning to market access, Eli Lilly has entered a $100 million licensing agreement with CSL Limited for clazakizumab. While CSL maintains the rights for kidney-related cardiovascular trials, Lilly ...